Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics.
Curr Pharm Des. 2024;30(1):31-47. doi: 10.2174/0113816128277350231219062154.
Curr Pharm Des. 2024.
PMID: 38151840
Review.
Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta-catenin signaling.
Sokolov D, Sharda N, Giri B, Hassan MS, Singh D, Tarasiewicz A, Lohr C, von Holzen U, Kristian T, Waddell J, Reiter RJ, Ahmed H, Banerjee A.
Sokolov D, et al.
J Pineal Res. 2022 Aug;73(1):e12808. doi: 10.1111/jpi.12808. Epub 2022 Jun 5.
J Pineal Res. 2022.
PMID: 35619550
Free PMC article.
Item in Clipboard
Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method.
Banerjee V, Sharda N, Huse J, Singh D, Sokolov D, Czinn SJ, Blanchard TG, Banerjee A.
Banerjee V, et al. Among authors: sokolov d.
Eur J Pharmacol. 2021 Apr 15;897:173919. doi: 10.1016/j.ejphar.2021.173919. Epub 2021 Feb 9.
Eur J Pharmacol. 2021.
PMID: 33577837
Item in Clipboard
Cite
Cite